{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:49:31Z","timestamp":1793245771138,"version":"4.5.0"},"reference-count":136,"publisher":"Baishideng Publishing Group Inc.","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3748\/wjg.v21.i13.3801","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T06:35:28Z","timestamp":1428993328000},"page":"3801","source":"Crossref","is-referenced-by-count":185,"title":["Gastrointestinal Beh\u00e7et's disease: A review"],"prefix":"10.3748","volume":"21","author":[{"given":"Wasseem","family":"Skef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411707"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/2040622314523062"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0058-4"},{"key":"ref4","unstructured":"Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990;335:1078-1080."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2013.12.005"},{"key":"ref6","unstructured":"Cakir N, Dervis E, Benian O, Pamuk ON, Sonmezates N, Rahimoglu R, Tuna S, Cetin T, Sarikaya Y. Prevalence of Behçet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 2004;22:S53-S55."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, Urgancio\u011flu M, Di\u015fçi R. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-806.","DOI":"10.1046\/j.1365-4362.2003.01893.x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0349-4"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Jaber L, Milo G, Halpern GJ, Krause I, Weinberger A. Prevalence of Behçet’s disease in an Arab community in Israel. Ann Rheum Dis 2002;61:365-366.","DOI":"10.1136\/ard.61.4.365"},{"key":"ref10","unstructured":"Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, Barghamdi M, Noorolahzadeh E, Khabazi AR, Salesi M. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 2008;35:1384."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2384-6"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1430-6"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.24423"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol 2000;30:144-154.","DOI":"10.1097\/00004836-200003000-00006"},{"key":"ref15","unstructured":"Grigg EL, Kane S, Katz S. Mimicry and deception in inflammatory bowel disease and intestinal behçet disease. Gastroenterol Hepatol (N Y) 2012;8:103-112."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0337-4"},{"key":"ref17","unstructured":"Vaiopoulos AG, Sfikakis PP, Kanakis MA, Vaiopoulos G, Kaklamanis PG. Gastrointestinal manifestations of Behçet’s disease: advances in evaluation and management. Clin Exp Rheumatol 2014;32:S140-S148."},{"key":"ref18","unstructured":"al-Dalaan AN, al Balaa SR, el Ramahi K, al-Kawi Z, Bohlega S, Bahabri S, al Janadi MA. Behçet’s disease in Saudi Arabia. J Rheumatol 1994;21:658-661."},{"key":"ref19","unstructured":"Chen YC, Chang HW. Clinical characteristics of Behçet’s disease in southern Taiwan. J Microbiol Immunol Infect 2001;34:207-210."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1127-9"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.107636"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.1.52"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Houman MH, Ben Ghorbel I, Lamloum M, Khanfir M, Braham A, Haouet S, Sayem N, Lassoued H, Miled M. Esophageal involvement in Behcet’s disease. Yonsei Med J 2002;43:457-460.","DOI":"10.3349\/ymj.2002.43.4.457"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-004-2975-2"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Tavakkoli H, Asadi M, Haghighi M, Esmaeili A. Therapeutic approach to “downhill” esophageal varices bleeding due to superior vena cava syndrome in Behcet’s disease: a case report. BMC Gastroenterol 2006;6:43.","DOI":"10.1186\/1471-230X-6-43"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Orikasa H, Ejiri Y, Suzuki S, Ishikawa H, Miyata M, Obara K, Nishimaki T, Kasukawa R. A case of Behçet’s disease with occlusion of both caval veins and “downhill” esophageal varices. J Gastroenterol 1994;29:506-510.","DOI":"10.1007\/BF02361251"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000112645"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Bottomley WW, Dakkak M, Walton S, Bennett JR. Esophageal involvement in Behçet’s disease. Is endoscopy necessary? Dig Dis Sci 1992;37:594-597.","DOI":"10.1007\/BF01307585"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1083-z"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Abe T, Yachi A, Yabana T, Ishii Y, Tosaka M, Yoshida Y, Yonezawa K, Ono A, Ikeda N, Matsuya M. Gastric non-Hodgkin’s lymphoma associated with Behçet’s disease. Intern Med 1993;32:663-667.","DOI":"10.2169\/internalmedicine.32.663"},{"key":"ref31","unstructured":"Arendt T, Kloehn S, Bastian A, Bewig B, Lins M, Mönig H, Fölsch UR. A case of Behçet‘s syndrome presenting with Dieulafoy‘s ulcer. Z Gastroenterol 1997;35:935-938."},{"key":"ref32","unstructured":"Ozenç A, Bayraktar Y, Baykal A. Pyloric stenosis with esophageal involvement in Behçet’s syndrome. Am J Gastroenterol 1990;85:727-728."},{"key":"ref33","unstructured":"Satake K, Yada K, Ikehara T, Umeyama K, Inoue T. Pyloric stenosis: an unusual complication of Behçet’s disease. Am J Gastroenterol 1986;81:816-818."},{"key":"ref34","unstructured":"Bertken R. Infliximab treatment of Behcet disease associated with severe gastroparesis Washington, DC, USA: The National Scientific Meeting of the American College of Rheumatology; 2001;."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H pylori infection in patients with Behcet’s disease. World J Gastroenterol 2007;13:2983-2985.","DOI":"10.3748\/wjg.v13.i21.2983"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Avci O, Ellidokuz E, Sim\u015fek I, Büyükgebiz B, Güne\u015f AT. Helicobacter pylori and Behçet’s disease. Dermatology 1999;199:140-143.","DOI":"10.1159\/000018221"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0725-2"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken216"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, Park IS, Bang D. Colonoscopic findings in intestinal Behçet’s disease. Inflamm Bowel Dis 2001;7:243-249.","DOI":"10.1097\/00054725-200108000-00010"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22991"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-006-0031-9"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-1095-7"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.585"},{"key":"ref44","unstructured":"Ibrahim M, Osoba AO. Abdominal tuberculosis. On-going challenge to gastroenterologists. Saudi Med J 2005;26:274-280."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12017"},{"key":"ref46","unstructured":"Amarapurkar DN, Patel ND, Amarapurkar AD, Agal S, Baigal R, Gupte P. Tissue polymerase chain reaction in diagnosis of intestinal tuberculosis and Crohn’s disease. J Assoc Physicians India 2004;52:863-867."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12091"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v5.i3.228"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol 2007;13:2028-2036.","DOI":"10.3748\/wjg.v13.i14.2028"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Filik L, Biyikoglu I. Differentiation of Behcet’s disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World J Gastroenterol 2008;14:7271.","DOI":"10.3748\/wjg.14.7271"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-006-0706-z"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1326-y"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.098368"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1103481"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Le Thi Huong D, Wechsler B, Dell’Isola B, Lautier-Frau M, Palazzo L, Bletry O, Piette JC, Godeau P. Acute pancreatitis in Behçet’s disease. Dig Dis Sci 1992;37:1452-1453.","DOI":"10.1007\/BF01296018"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Backmund M, Schomerus P. Acute pancreatitis and pericardial effusion in Behçet’s disease. Gastroenterology 1999;117:286.","DOI":"10.1016\/S0016-5085(99)70598-6"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Alkim H, Gürkaynak G, Sezgin O, O\u011fuz D, Sarita\u015f U, Sahin B. Chronic pancreatitis and aortic pseudoaneurysm in Behçet’s disease. Am J Gastroenterol 2001;96:591-593.","DOI":"10.1111\/j.1572-0241.2001.03564.x"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985;16:790-795.","DOI":"10.1016\/S0046-8177(85)80250-1"},{"key":"ref59","unstructured":"Chawla S, Atten MJ, Attar BM. Acute pancreatitis as a rare initial manifestation of Wegener’s granulomatosis. A case based review of literature. JOP 2011;12:167-169."},{"key":"ref60","unstructured":"Kuniyoshi Y, Koja K, Miyagi K, Uezu T, Yamashiro S, Arakaki K, Mabuni K, Senaha S. Surgical treatment of Budd-Chiari syndrome induced by Behcet’s disease. Ann Thorac Cardiovasc Surg 2002;8:374-380."},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.gcb.2007.12.022"},{"key":"ref62","unstructured":"Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behçet’s disease. Am J Gastroenterol 1997;92:858-862."},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Korkmaz C, Kasifoglu T, Kebapçi M. Budd-Chiari syndrome in the course of Behcet’s disease: clinical and laboratory analysis of four cases. Joint Bone Spine 2007;74:245-248.","DOI":"10.1016\/j.jbspin.2006.06.015"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283410088"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Orloff LA, Orloff MJ. Budd-Chiari syndrome caused by Behçet’s disease: treatment by side-to-side portacaval shunt. J Am Coll Surg 1999;188:396-407.","DOI":"10.1016\/S1072-7515(99)00012-5"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Manna R, Ghirlanda G, Bochicchio GB, Papa G, Annese V, Greco AV, Taranto CA, Magaro M. Chronic active hepatitis and Behçet’s syndrome. Clin Rheumatol 1985;4:93-96.","DOI":"10.1007\/BF02032326"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i20.3165"},{"key":"ref68","unstructured":"Hisaoka M, Haratake J, Nakamura T. Small bile duct abnormalities and chronic intrahepatic cholestasis in Behçet’s syndrome. Hepatogastroenterology 1994;41:267-270."},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8064-8"},{"key":"ref70","unstructured":"Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S. Vascular involvement in Behçet’s disease. J Rheumatol 1992;19:402-410."},{"key":"ref71","unstructured":"Lie JT. Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 1992;19:341-343."},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Sarica-Kucukoglu R, Akdag-Kose A, KayabalI M, Yazganoglu KD, Disci R, Erzengin D, Azizlerli G. Vascular involvement in Behçet’s disease: a retrospective analysis of 2319 cases. Int J Dermatol 2006;45:919-921.","DOI":"10.1111\/j.1365-4632.2006.02832.x"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2011.05.010"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in behcet disease: a cumulative analysis. Chest 2005;127:2243-2253.","DOI":"10.1378\/chest.127.6.2243"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Umehara N, Saito S, Ishii H, Aomi S, Kurosawa H. Rupture of thoracoabdominal aortic aneurysm associated with Behcet’s disease. Ann Thorac Surg 2007;84:1394-1396.","DOI":"10.1016\/j.athoracsur.2007.04.110"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0278-2"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivr041"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1177\/0218492310387702"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0232-3"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Planer D, Verstandig A, Chajek-Shaul T. Transcatheter embolization of renal artery aneurysm in Behçet’s disease. Vasc Med 2001;6:109-112.","DOI":"10.1177\/1358836X0100600207"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Arishiro K, Nariyama J, Hoshiga M, Nakagawa A, Okabe T, Nakakoji T, Negoro N, Ishihara T, Hanafusa T. Vascular Behçet’s disease with coronary artery aneurysm. Intern Med 2006;45:903-907.","DOI":"10.2169\/internalmedicine.45.1582"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Basaranoglu G, Basaranoglu M. Behcet’s disease complicated with celiac trunk aneurysm. J Clin Gastroenterol 2001;33:174-175.","DOI":"10.1097\/00004836-200108000-00023"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Chubachi A, Saitoh K, Imai H, Miura AB, Kotanagi H, Abe T, Matsumoto T. Case report: intestinal infarction after an aneurysmal occlusion of superior mesenteric artery in a patient with Behçet’s disease. Am J Med Sci 1993;306:376-378.","DOI":"10.1097\/00000441-199312000-00004"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s003300000369"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Dolar E, Uslusoy H, Kiyici M, Gurel S, Nak SG, Gulten M, Zorluoglu A, Saricaoglu H, Memik F. Rupture of the splenic arterial aneurysm due to Behcet’s disease. Rheumatology (Oxford) 2005;44:1327-1328.","DOI":"10.1093\/rheumatology\/keh725"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/S0741"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0578-8"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.331"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21313"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i40.5771"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21600"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.087957"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-007-2090-4"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0872-4"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182431d56"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-014-0488-0"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21757"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M. Anti-TNF therapy in the management of Behcet’s disease--review and basis for recommendations. Rheumatology (Oxford) 2007;46:736-741.","DOI":"10.1093\/rheumatology\/kem034"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. Treatment of intestinal Behçet’s syndrome with chimeric tumour necrosis factor alpha antibody. Gut 2001;49:725-728.","DOI":"10.1136\/gut.49.5.725"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Hassard PV, Binder SW, Nelson V, Vasiliauskas EA. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet’s disease: a case report. Gastroenterology 2001;120:995-999.","DOI":"10.1053\/gast.2001.22556"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20457"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep126"},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Kinoshita H, Kunisaki R, Yamamoto H, Matsuda R, Sasaki T, Kimura H, Tanaka K, Naganuma M, Maeda S. Efficacy of infliximab in patients with intestinal Behçet’s disease refractory to conventional medication. Intern Med 2013;52:1855-1862.","DOI":"10.2169\/internalmedicine.52.0589"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828f19c9"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.03.006"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20869"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM. Adalimumab: a new modality for Behçet’s disease? Ann Rheum Dis 2007;66:565-566.","DOI":"10.1136\/ard.2006.064279"},{"key":"ref108","unstructured":"Shimizu Y, Takeda T, Matsumoto R, Yoshida K, Nakajima J, Atarashi T, Yanagisawa H, Kikuchi K, Kikuchi H. [Clinical efficacy of adalimumab for a postoperative marginal ulcer in gastrointestinal Behçet disease]. Nihon Shokakibyo Gakkai Zasshi 2012;109:774-780."},{"key":"ref109","unstructured":"Sylwestrzak G, Liu J, Stephenson JJ, Ruggieri AP, DeVries A. Considering patient preferences when selecting anti-tumor necrosis factor therapeutic options. Am Health Drug Benefits 2014;7:71-81."},{"key":"ref110","unstructured":"Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y. Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease. Clin Gastroenterol Hepatol 2014;Epub ahead of print."},{"key":"ref111","unstructured":"Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V, Yazici H. Short-term trial of etanercept in Behçet’s disease: a double blind, placebo controlled study. J Rheumatol 2005;32:98-105."},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2628-5"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Sandborn WJ, Hanauer SB, Katz S, Safdi M, Wolf DG, Baerg RD, Tremaine WJ, Johnson T, Diehl NN, Zinsmeister AR. Etanercept for active Crohn’s disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2001;121:1088-1094.","DOI":"10.1053\/gast.2001.28674"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080432"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"Seyahi E, Hamuryudan V, Hatemi G, Melikoglu M, Celik S, Fresko I, Yurdakul S, Yazici H. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet’s syndrome. Rheumatology (Oxford) 2007;46:1213-1214.","DOI":"10.1093\/rheumatology\/kem103"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.09.052"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21517"},{"key":"ref118","unstructured":"Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H, Kanai T, Watanabe M, Hibi T. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet’s disease. Am J Gastroenterol 2000;95:2848-2851."},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 1981;24:103-106.","DOI":"10.1007\/BF02604297"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-004-0495-4"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1583\/09-2812.1"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2351-9"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS, Kim CY. Long-term clinical course and prognostic factors in intestinal Behçet’s disease. Dis Colon Rectum 2000;43:692-700.","DOI":"10.1007\/BF02235590"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181c8a50f"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9012"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2013.54.5.1084"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21833"},{"key":"ref128","unstructured":"Kim DK, Yang SK, Byeon JS, Myung SJ, Jo JY, Choi KD. Clinical manifestations and course of intestinal Behçet’s disease: an analysis in relation to diaesase subtypes. Intest Res 2005;3:48-54."},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1002\/art.27568"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0132-z"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20317"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D524"},{"key":"ref133","unstructured":"Postema PT, den Haan P, van Hagen PM, van Blankenstein M. Treatment of colitis in Behçet’s disease with thalidomide. Eur J Gastroenterol Hepatol 1996;8:929-931."},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02161_13.x"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-010-0370-y"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20970"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i13\/3801.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T01:29:58Z","timestamp":1651714198000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i13\/3801.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":136,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v21.i13.3801","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}